Could Merck’s acquisition of Schering-Plough trigger a slew of M&A deals?
Stocks retreated in a yo-yo session as an earlier advance in the shares of energy and big-cap technology companies dissipated. But banks held gains as investors hoped for more clarity on the government plan to firm up the financial system, with Fed Chairman Ben Beranke meeting with President Obama today.
Raising taxes despite a recession? Changing the mortgage deduction during a housing crisis? Cramer finds fault with the White House's plans.
Traders were more excited about GE stabilizing and U.S. banks not dropping on a day when European banks are down, than about the Schering deal.
This is part one of the preliminary transcript and video clips of Warren Buffett's appearances on CNBC's Squawk Box on Monday, March 9, 2009.
Stock index futures pointed to a lower open for Wall Street, but were off the day's lows as Dow component Merck announced it will merge with Schering-Plough in a cash and stock deal.
The president’s budget changes sent stocks tumbling, some undeservedly so.
Robert Lloyd of the AIM Summit Fund is not banking on a quick recovery in the economy. So what's his investment strategy?
After a great run, healthcare stocks got killed last week. What’s the trade now?
Stocks tumbled Friday and the S&P hit a 12-year low as news of the government's stake in Citigroup and General Electric slashing its dividend stirred worry in the market.
In today's initial sell off, the Dow was down over 50% since its Oct 2007 peak. Here are more key dates for the Dow & S&P, both on a closing and intraday basis:
Pledging "a new era of responsibility," President Barack Obama unveiled a multi-trillion-dollar spending plan.
The Dow fell in volatile trade on Thursday with Merck being one of the biggest drags on the blue chip index, as investors worried that the budget proposal could strangle profits.
It was another down day on Wall Street as health-care stocks tanked amid worries that President Obama's budget will clamp industry profits.
Is there such a thing as a safe dividend yield? RNC Genter Capital Management's Dan Genter says an investor should look not to the size of the dividend, not even in relation to the stock price, but to consistency.
This morning the world's biggest pharmaceutical firm announced that it's scrapping two more drugs that were in late-stage studies.
Despite the ongoing recession, generic drug makers like Teva Pharmaceutical and Watson Pharmaceutical have been outperforming in the broader market. CEOs William Marth and Paul Bisaro both expect to see further growth.
Cramer makes the call on viewers' favorite stocks.
CNBC's "Power Lunch" team asked some of the best and the brightest from America's big financial firms to list the most promising stocks. Strategists from Citigroup, Goldman Sachs, Cowen & Co. and Deutsche Bank offered CNBC their stock picks.
Stocks turned mixed Wednesday as some disappointing earnings reports cast a pall over a pair of better-than-expected readings on the economy.